New Zealand’s Science Sector to Undergo Biggest Reforms in 30 Years

Summary

The New Zealand Government has announced the biggest reforms to the science sector in 30 years as part of a package to accelerate economic growth. Prime Minister Christopher Luxon said the changes aim to double exports by 2034 and maximise the value of NZ$1.2 billion annual science spending. The core change is restructuring seven Crown Research Institutes into three new public research organisations, focusing on earth sciences, bioeconomy, health and forensic science, which will seek private sector investment.

A new New Zealand Investment Agency will be established to promote foreign direct investment, and a new national intellectual property management policy is planned to allow researchers to profit from their work. The Government will also lift a 30-year ban on genetic engineering research, allowing field trials. However, scientists note the reforms do not address long-term underinvestment: New Zealand's public science spending as a share of GDP is about half that of Denmark.

As a cost-cutting measure, several Crown Research Institutes laid off hundreds of staff last year and plan to close Callaghan Innovation, which employs nearly 400 people. Many scientists are leaving New Zealand due to reduced funding for basic research. The reform plan adopts some recommendations from an advisory panel but downplays warnings not to expect huge or immediate returns.

New funding is unlikely until the 2026 budget, and the reforms may lead to more job losses in the science sector.

Commentary

For small and medium enterprise (SME) owners, the reforms pose short-term uncertainty but may bring new business opportunities in the long run. On one hand, the restructuring of Crown Research Institutes and closure of Callaghan Innovation mean SMEs that rely on these bodies for R&D support or collaboration may lose access to technology incubation, commercialisation guidance and partnership channels in the near term. An exodus of scientists could weaken New Zealand's overall R&D capability, affecting technical consulting and talent recruitment.

On the other hand, lifting the genetic engineering ban opens a new window for SMEs in agriculture and biotechnology – if legislation passes, they could conduct field trials of genetically modified crops, develop high-value varieties, or boost export competitiveness. The new IP policy encourages researchers to profit from their work, allowing SMEs more flexibility to access innovative technologies through patent licensing or collaborative development. Additionally, the New Zealand Investment Agency's efforts to attract foreign capital may drive local supply chain demand, for instance by providing ancillary services to incoming international tech firms.

However, the reforms emphasise a commercialisation focus, and the weakening of basic research may undermine long-term innovation foundations. SMEs relying on public scientific knowledge should assess changes in access channels. It is advisable to monitor the 2026 budget funding allocation and the specific cooperation models of the new bodies, adjusting technology strategies accordingly.

Looking ahead, the genetic engineering lift and new investment agency could create niche opportunities for SMEs, but policy implementation details are awaited.

Keywords: New Zealand, science reform, Crown Research Institutes, genetic engineering, investment agency, intellectual property, commercialisation, research organisations, job cuts, economic growth

Source: Sohu